JAGUAR HEALTH INC (JAGX) Forecast, Price Target & Analyst Ratings
NASDAQ:JAGX • US47010C8881
0.5905 USD
-0.01 (-1.94%)
At close: Mar 6, 2026
0.5799 USD
-0.01 (-1.8%)
After Hours: 3/6/2026, 8:27:49 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for JAGUAR HEALTH INC (JAGX).
Forecast Snapshot
Consensus Price Target
$16.32
+ 2,663.76% Upside
Next Earnings Forecast
Release DateMar 30, 2026
PeriodQ4 / 2025
EPS Estimate-$4.35
Revenue Estimate4.295M
ChartMill Buy Consensus
85.71%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$16.32
Upside
+ 2,663.76%
From current price of $0.59 to mean target of $16.32, Based on 7 analyst forecasts
Low
$16.16
Median
$16.32
High
$16.80
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 analysts have analysed JAGX and the average price target is 16.32 USD. This implies a price increase of 2663.76% is expected in the next year compared to the current price of 0.5905.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.71%
JAGX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about JAGX.
In the previous month the buy percentage consensus was at a similar level.
JAGX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-05-19 | First Berlin | Initiate | Buy |
| 2021-07-07 | Cantor Fitzgerald | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 30, 2026
PeriodQ4 / 2025
EPS Estimate-$4.35
Revenue Estimate4.295M
Revenue Q2Q23.95%
EPS Q2Q-1,178.00%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
JAGX is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is -4.35 USD and the consensus revenue estimate is 4.29M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 11.956M 175.80% | 9.761M -18.36% | 11.689M 19.75% | 14.308M 22.41% | 18.6M 30.00% | 204M 996.77% | 389.44M 90.90% | 573.95M 47.38% | 682.99M 19.00% | |
| EBITDA YoY % growth | -32.434M 13.17% | -31.907M 1.62% | -28.931M 9.33% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -34.415M 11.92% | -33.92M 1.44% | -30.831M 9.11% | -28.509M 7.53% | -23.633M 17.10% | 105.67M 547.12% | 260.3M 146.33% | 415.85M 59.76% | 509.49M 22.52% | |
| Operating Margin | -287.85% | -347.51% | -263.76% | -199.25% | -127.06% | 51.80% | 66.84% | 72.45% | 74.60% | |
| EPS YoY % growth | N/A 99.96% | N/A 89.90% | -232.59 -3,811.31% | -24.29 89.56% | -5.79 76.14% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -4.35 -1,178.00% | -2.08 87.54% | -1.52 85.19% | -1.19 81.00% | -1.30 70.19% |
| Revenue Q2Q % growth | 4.295M 23.95% | 3.741M 68.97% | 4.33M 47.48% | 4.945M 60.40% | 5.583M 29.99% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.089M 0.84% | -5.62M 40.34% | -5.467M 31.72% | -5.375M 25.73% | -7.181M 11.22% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
160.53%
Revenue Next 5 Year
118.46%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
JAGUAR HEALTH INC / JAGX Forecast FAQ
What is the price target for JAGX stock?
7 analysts have analysed JAGX and the average price target is 16.32 USD. This implies a price increase of 2663.76% is expected in the next year compared to the current price of 0.5905.
When does JAGUAR HEALTH INC (JAGX) report earnings?
JAGUAR HEALTH INC (JAGX) will report earnings on 2026-03-30, after the market close.
What are the consensus estimates for JAGX stock next earnings?
The consensus EPS estimate for the next earnings of JAGUAR HEALTH INC (JAGX) is -4.35 USD and the consensus revenue estimate is 4.29M USD.
What is the expected long term growth rate for JAGX stock?
The expected long term growth rate for JAGUAR HEALTH INC (JAGX) is 160.53%.